Cancer News
'Co-Rounding' Cuts Inpatient Oncology Stays, Readmissions

Money Woes Spawn Cancer Patient Treatment Shortcuts

Genetic Test Showing Increased CRC Risk Prompts No Action

Got Colon Cancer, Get Milk?

EHRs Not Living Up to the Hype
When heart cancer hides in the brain: how a lucky coincidence led to rare diagnosis

Knowing individual risk does not increase cancer screening rates

Clinical trial demonstrates prolonged survival for advanced multiple myeloma patients

New approach to monitoring changes in cellular structure may lead to early detection of cancerous cells

3-D printed facial prosthesis offers new hope for eye cancer patients following surgery
Mutations Linked to Blood Cancers Rise With Age, Study Shows

Y Chromosome Loss May Predict Earlier Death for Men

Gene May Help Shield Hispanic Women From Breast Cancer, Study Says

Healthy Lifestyle May Boost Breast Cancer Survival

Medicare Subsidy Helps Breast Cancer Patients Afford Treatment
Patient Profile: Liana's Looms of Love

UCLA Vice Chancellor for Research Elected to Institute of Medicine

UCLA Cancer Researcher Receives Prestigious Innovator Award for Developing New Ways to Use Blood Stem Cells to Attack Cancer

Leading-Edge Lung Cancer Treatment Advances with $1M Grant to UCLA Scientists

Melanoma Drug Combo Improves Patient Survival Rate, Decreases Risk of Harsh Side Effect
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): A randomised, double-blind, phase 3 trial

Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment

A tissue biomarker based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02

A preoperative serum signature of CEA+/CA125+/CA19-9 ≥1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer

The predictive and prognostic value of the Glasgow Prognostic Score in metastatic colorectal carcinoma patients receiving bevacizumab